Alx Oncology Holdings (ALXO) Treasury Shares (2019 - 2020)

Alx Oncology Holdings has reported Treasury Shares for 7 years, with the latest figure at $60750.0 in Q3 2025.

• Quarterly Treasury Shares changed N/A year-over-year to $60750.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $60750.0 (changed N/A YoY) and the FY2025 annual result came in at $57750.0, down 95.4% from the prior year.
• Treasury Shares declined to $60750.0 in Q3 2025 per ALXO's latest filing, from $69750.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $1.3 million in Q4 2024 and troughed at $15075.0 in Q4 2021.
• A 5-year average of $510817.3 and a median of $496974.5 in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2023: Treasury Shares surged 5341.63% in 2022, then advanced 15.77% in 2023.
• Over 5 years, Treasury Shares stood at $15075.0 in 2021, then soared by 5341.63% to $820326.0 in 2022, then rose by 15.77% to $949669.0 in 2023, then soared by 32.28% to $1.3 million in 2024, then sank by 95.16% to $60750.0 in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $60750.0, $69750.0, and $72000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.